Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline added to mometasone furoate for persistent rhinitis
TCTR20210221003Phase 4Recruiting
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oxymetazoline and mometasone in chronic rhinitis, allergic rhinitis (AR) and non-allergic rhinitis (NAR) (2 arms), sponsored by Faculty of Medicine, Prince of Songkhla University. Primary endpoint: Nasal symptoms score at week 6. Started Aug 2014; status: recruiting.
02
Drugs
oxymetazolinemometasone
03
Conditions
chronic rhinitisallergic rhinitis (AR)non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on TCTR20210221003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210221003.